487 related articles for article (PubMed ID: 9669397)
1. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
5. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
6. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.
Kao CH; Tsai SC; Liu TJ; Ho YJ; Wang JJ; Ho ST; ChangLai SP
Cancer Res; 2001 Feb; 61(4):1412-4. PubMed ID: 11245443
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
[TBL] [Abstract][Full Text] [Related]
9. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.
Wang H; Chen XP; Qiu FZ
World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Kabasakal L; Ozker K; Hayward M; Akansel G; Griffith O; Isitman AT; Hellman R; Collier D
Eur J Nucl Med; 1996 May; 23(5):568-70. PubMed ID: 8698063
[TBL] [Abstract][Full Text] [Related]
12. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
[TBL] [Abstract][Full Text] [Related]
13. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
[TBL] [Abstract][Full Text] [Related]
15. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-Tetrofosmin.
Perek N; Koumanov F; Denoyer D; Boudard D; Dubois F
Cancer Biother Radiopharm; 2002 Jun; 17(3):291-302. PubMed ID: 12136521
[TBL] [Abstract][Full Text] [Related]
18. Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Cordobes MD; Moretti JL; de Beco V; Benazzouz F; Starzec A
Nucl Med Commun; 1999 May; 20(5):433-7. PubMed ID: 10404528
[TBL] [Abstract][Full Text] [Related]
19. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake.
Perek N; Le Jeune N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Aug; 20(4):391-400. PubMed ID: 16114987
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.
Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y
Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
